The prevalence and clinical spectrum of post-Covid syndrome in patients with rheumatic diseases: a single-center experience

Creative Commons License

Batibay S., Ulucakoy R. K., Gunendi Z., GÖĞÜŞ F. N.

REUMATISMO, cilt.74, sa.1, ss.22-28, 2022 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 74 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.4081/reumatismo.2022.1481
  • Dergi Adı: REUMATISMO
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.22-28
  • Anahtar Kelimeler: COVID-19, post COVID-19 syndrome, rheumatology, long COVID, inflammatory rheumatic disease
  • Gazi Üniversitesi Adresli: Evet

Özet

Post-coronavirus disease (COVID) syndrome (PCS) is a term used to describe the clinical condition of patients who have recovered from COVID-19 but are still experiencing prolonged effects of infection or persistent symptoms for longer than expected. Although PCS has been previously studied in the general population, it has not been investigated in a specific population of patients with inflammatory rheumatic disease (IRD). This study aims to evaluate the presence and frequency of PCS among our rheumatology outpatients.